Get a quote

42ND ETCE EVENT sponsored by TAKEDA

42ND ETCE EVENT sponsored by TAKEDA

IN courses
portfolio
Course Director:
Dr. Guido Giusti
Course Vice Director:
Dr. Silvia Proietti
Course date:
15th September 2014
Where:
Milan, Italy
Venue:
Humanitas Research Hospital, IRCSS
Sponsored by:
TAKEDA
About Course

Description:

1 supine PCNL and 3 RIRS for urolithiasis have been carried out uneventfully.
Picture 1: Coronal CT scan of the 1st patient (left supine tubeless PCNL): a 3 cm renal stone (HU 1400) is showed in the left renal pelvis with severe hydronephrosis.
Picture 2: Axial CT scan of the 2nd patient (right RIRS): 2 renal stones (HU 900) are showed in the right kidney.
Picture 3: Coronal CT scan of the 3rd patient (left RIRS): multiple residual fragments in the left kidney (HU 700) are showed in a patient who previously underwent RIRS in an other hospital.
Picture 4: Axial CT scan of the 4th patient (left kidney): a 2 cm renal stone (HU 1200) of the lower calyx is showed in a patient affected by continuous gravative lumbar pain..

Participants:

Dr De Marco Vincenzo, Urologist at Policlinico Rossi, University of Verona, Verona (Italy)
Dr John Alexander Joseph Lovisolo, Urologist at Saronno Hospital, Bursto Arsizio (Italy)
Dr. Carmelo Morana, Urologist at Policlinico S. Giorgio, Pordenone (Italy)
Dr. Giovanni Zanon, Urologist at Conegliano Hospital, Conegliano (Italy)
Dr. Stefano Zambito, Urologist at Desio Hospital, Desio (Italy)

Together with:

Mr Olivio Vicardi, Sales Representative, Takeda, Italy
Miss Laura Biggi, Area Manager, Boston Scientific Italy
Mr. Salvo Callea, Sales Representative, Karl Storz Italy


This site uses cookies to provide the best browsing experience possible. Cookies managed by third parties are always treated anonymously. Click on accept to continue browsing. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close